n,n-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride has been researched along with Aortic Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukunaga, K; Han, F; Ishida, K; Kobayashi, T; Matsumoto, T; Nemoto, S; Tagashira, H; Taguchi, K; Zhang, C | 1 |
1 other study(ies) available for n,n-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride and Aortic Diseases
| Article | Year |
|---|---|
Vascular endothelial σ1-receptor stimulation with SA4503 rescues aortic relaxation via Akt/eNOS signaling in ovariectomized rats with aortic banding.
Topics: Adrenergic alpha-1 Receptor Agonists; Animals; Anisoles; Antipsychotic Agents; Aorta, Abdominal; Aortic Diseases; Cyclic GMP; Endothelin-1; Endothelium, Vascular; Female; Muscle, Smooth, Vascular; Nitric Oxide Synthase Type III; Nootropic Agents; Ovariectomy; Phenylephrine; Phosphorylation; Piperazines; Propylamines; Proto-Oncogene Proteins c-akt; Rats, Wistar; Receptors, sigma; Sigma-1 Receptor; Vasodilation | 2013 |